Skip to main content
Erschienen in: Clinical Oral Investigations 3/2014

01.04.2014 | Original Article

Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients

verfasst von: Yi-Shing Lisa Cheng, Lee Jordan, Terry Rees, Huey-Shys Chen, Lance Oxford, Ole Brinkmann, David Wong

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To gather preliminary data concerning the feasibility of using seven salivary mRNAs—IL-8; IL-1β; dual specificity phosphatase 1 (DUSP1); H3 histone family 3A (H3F3A); ornithin decarboxylase antizyme 1 (OAZ1); S100 calcium-binding protein P (S100P); and spermidine/spermine N1-acetyltransferase 1 (SAT1)—for detecting development of oral squamous cell carcinoma (OSCC) in oral lichen planus (OLP) patients and OSCC patients whose disease was in remission.

Materials and methods

Saliva samples were collected from five study groups (25 subjects/group): newly diagnosed OSCC, OSCC-in-remission, disease-active OLP, disease-inactive OLP, and normal controls. The salivary mRNA levels were determined by a pre-amplification RT-qPCR approach with nested gene-specific primers. Mean fold changes between each pair of study groups were analyzed by the Mann–Whitney U test.

Results

Salivary levels of OAZ1, S100P, and DUSP1 mRNAs were significantly higher in newly diagnosed OSCC patients, compared to: (1) normal controls (p = 0.003; p = 0.003; and p < 0.001, respectively); (2) OSCC-in-remission (p < 0.001; p = 0.001; and p < 0.001, respectively); (3) disease-active OLP (p < 0.001; p = 0.016; and p < 0.001, respectively); and (4) disease-inactive OLP (p = 0.043; p < 0.001; and p < 0.001, respectively). No significant differences were found in the levels of salivary IL-8, IL-1β, H3F3A, and SAT1 mRNAs between newly diagnosed OSCC patients and the normal controls (p = 0.093, 0.327, 0.764, and 0.560, respectively).

Conclusion

Salivary OAZ1, S100P, and DUSP1 mRNAs are candidate biomarkers for detecting OSCC development in OSCC patients in remission and in OLP patients.

Clinical relevance

The results of this study serve as the basis for a further large-scale study which may lead to a non-invasive screening method for early detection of OSCC.
Literatur
1.
Zurück zum Zitat Wu J, Yi C, Chung H, Wang D, Chang W, Lee S, Lin C, Yang Y, Yang W (2010) Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 46:226–231PubMedCrossRef Wu J, Yi C, Chung H, Wang D, Chang W, Lee S, Lin C, Yang Y, Yang W (2010) Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 46:226–231PubMedCrossRef
2.
Zurück zum Zitat Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F (2005) The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 44(2):77–82PubMedCrossRef Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F (2005) The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 44(2):77–82PubMedCrossRef
3.
Zurück zum Zitat Hoffmann RR, Yurgel LS, Campos MM (2011) Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia. Regul Pept 166(1–3):55–58PubMedCrossRef Hoffmann RR, Yurgel LS, Campos MM (2011) Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia. Regul Pept 166(1–3):55–58PubMedCrossRef
4.
Zurück zum Zitat Cheng YS, Rees T, Jordan L, Oxford L, O’Brien J, Chen HS, Wong D (2011) Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol 47(12):1122–1126PubMedCentralPubMedCrossRef Cheng YS, Rees T, Jordan L, Oxford L, O’Brien J, Chen HS, Wong D (2011) Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol 47(12):1122–1126PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Gorugantula L, Rees T, Plemons J, Chen H, Cheng YS (2012) Salivary basic fibroblast growth factor in patients with oral squamous cell carcinoma or oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol 114(2):215–222PubMedCentralPubMedCrossRef Gorugantula L, Rees T, Plemons J, Chen H, Cheng YS (2012) Salivary basic fibroblast growth factor in patients with oral squamous cell carcinoma or oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol 114(2):215–222PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10(24):8442–8450PubMedCrossRef Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10(24):8442–8450PubMedCrossRef
7.
Zurück zum Zitat Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, Nesic VS, Markovic SZ, Martinovic ZR, Akin D, Spielmann N, Zhou H, Wong DT (2011) Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol 47(1):51–55PubMedCentralPubMedCrossRef Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, Nesic VS, Markovic SZ, Martinovic ZR, Akin D, Spielmann N, Zhou H, Wong DT (2011) Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol 47(1):51–55PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A, Messadi D, Wang M, Nabili V, Lingen M, Morris D, Randolph T, Feng Z, Akin D, Kastratovic DA, Chia D, Abemayor E, Wong DT (2012) Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev 21(4):664–672PubMedCentralPubMedCrossRef Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A, Messadi D, Wang M, Nabili V, Lingen M, Morris D, Randolph T, Feng Z, Akin D, Kastratovic DA, Chia D, Abemayor E, Wong DT (2012) Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev 21(4):664–672PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Hu Z, Zimmermann BG, Zhou H, Wang J, Henson BS, Yu W, Elashoff D, Krupp G, Wong DT (2008) Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem 54(5):824–832PubMedCentralPubMedCrossRef Hu Z, Zimmermann BG, Zhou H, Wang J, Henson BS, Yu W, Elashoff D, Krupp G, Wong DT (2008) Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem 54(5):824–832PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Pfaffl M (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nuclei Acids Res 29(9):2002–2007CrossRef Pfaffl M (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nuclei Acids Res 29(9):2002–2007CrossRef
12.
Zurück zum Zitat Heller J, Fong W, Canellakis E (1976) Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc Natl Acad Sci U S A 73:1858–1862PubMedCentralPubMedCrossRef Heller J, Fong W, Canellakis E (1976) Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Proc Natl Acad Sci U S A 73:1858–1862PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Pegg A (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48:759–774PubMed Pegg A (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48:759–774PubMed
14.
Zurück zum Zitat Shantz L, Levin V (2007) Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential. Amino Acids 33:213–223PubMedCrossRef Shantz L, Levin V (2007) Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential. Amino Acids 33:213–223PubMedCrossRef
15.
Zurück zum Zitat Koike C, Chan D, Zetter B (1999) Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. Cancer Res 59:6109–6112PubMed Koike C, Chan D, Zetter B (1999) Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. Cancer Res 59:6109–6112PubMed
16.
Zurück zum Zitat Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, Igarashi k, Mizutani S (1999) Anti-tumor activity of antizyme which targets the ornithine carboxylase (ODC) required for cell growth and transformation. Oncogene 18:165–172PubMedCrossRef Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, Igarashi k, Mizutani S (1999) Anti-tumor activity of antizyme which targets the ornithine carboxylase (ODC) required for cell growth and transformation. Oncogene 18:165–172PubMedCrossRef
17.
Zurück zum Zitat Tsuji T, Usui S, Aida T, Tachikawa T, Hu G, Sasaki A, Matusumura T, Todd R, Wong D (2001) Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme. Oncogene 20:24–33PubMedCrossRef Tsuji T, Usui S, Aida T, Tachikawa T, Hu G, Sasaki A, Matusumura T, Todd R, Wong D (2001) Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme. Oncogene 20:24–33PubMedCrossRef
18.
Zurück zum Zitat Tsuji T, Katasurano M, Ibaragi S, Shima K, Sasaki A, Hu G (2007) Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells. Biochemistry 46(31):8920–8932PubMedCrossRef Tsuji T, Katasurano M, Ibaragi S, Shima K, Sasaki A, Hu G (2007) Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells. Biochemistry 46(31):8920–8932PubMedCrossRef
19.
Zurück zum Zitat Rom E, Kahana C (1994) Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. Proc Natl Acad Sci U S A 91:3959–3963PubMedCentralPubMedCrossRef Rom E, Kahana C (1994) Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. Proc Natl Acad Sci U S A 91:3959–3963PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Salama I, Malone P, Mihaimeed F, Jones J (2008) A review of the S100 proteins in cancer. EJSO 34:357–364PubMedCrossRef Salama I, Malone P, Mihaimeed F, Jones J (2008) A review of the S100 proteins in cancer. EJSO 34:357–364PubMedCrossRef
21.
Zurück zum Zitat Gibadulinova A, Tothova V, Pastorek J, Pastorekova S (2011) Transcriptional regulation and functional implication of S100P in cancer. Amino Acids 41:885–892PubMedCrossRef Gibadulinova A, Tothova V, Pastorek J, Pastorekova S (2011) Transcriptional regulation and functional implication of S100P in cancer. Amino Acids 41:885–892PubMedCrossRef
22.
Zurück zum Zitat Kupferman M, Patel V, Sriuranpong V, Amornphimoltham P, Jasser S, Mandal M, Zhou G, Wang J, Coombes K, Multani A, Pathak S, Gutkind J, Myers J (2007) Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Oral Oncol 43(5):440–454PubMedCrossRef Kupferman M, Patel V, Sriuranpong V, Amornphimoltham P, Jasser S, Mandal M, Zhou G, Wang J, Coombes K, Multani A, Pathak S, Gutkind J, Myers J (2007) Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Oral Oncol 43(5):440–454PubMedCrossRef
23.
Zurück zum Zitat Sapkota D, Bruland O, Bue O, Bakcer H, Elgindi O, Vasstrand E, Ibruhim S (2008) Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med 37:607–615PubMedCrossRef Sapkota D, Bruland O, Bue O, Bakcer H, Elgindi O, Vasstrand E, Ibruhim S (2008) Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med 37:607–615PubMedCrossRef
24.
Zurück zum Zitat Patterson K, Brummer T, O’Brien P, Daly R (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418:475–489PubMed Patterson K, Brummer T, O’Brien P, Daly R (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418:475–489PubMed
25.
Zurück zum Zitat Zhang Y, Lin M, Zhang S, Wang Z, Jiang L, Shen J, Bai J, Gao F, Zhou M, Chen Q (2008) NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine 41(2):144–149PubMedCrossRef Zhang Y, Lin M, Zhang S, Wang Z, Jiang L, Shen J, Bai J, Gao F, Zhou M, Chen Q (2008) NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine 41(2):144–149PubMedCrossRef
26.
Zurück zum Zitat Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F (2005) A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114(3):278–283PubMedCrossRef Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F (2005) A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114(3):278–283PubMedCrossRef
27.
Zurück zum Zitat Yamamoto T, Osaki T (1995) Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 104:784–788PubMedCrossRef Yamamoto T, Osaki T (1995) Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 104:784–788PubMedCrossRef
Metadaten
Titel
Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients
verfasst von
Yi-Shing Lisa Cheng
Lee Jordan
Terry Rees
Huey-Shys Chen
Lance Oxford
Ole Brinkmann
David Wong
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 3/2014
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-013-1041-0

Weitere Artikel der Ausgabe 3/2014

Clinical Oral Investigations 3/2014 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.